Promiscuous affairs of PKB/AKT isoforms in metabolism

References

• Altomare DA, Testa JR. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene 24:7455–64.
   PubMed Web of Science ®Google Scholar
• Bae SS, Cho H, Mu J, Birnbaum MJ. (2003). Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278:49530–36.
   PubMed Web of Science ®Google Scholar
• Berggreen C, Gormand A, Omar B, Degerman E, Goransson O. (2009). Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am J Physiol Endocrinol Metab 296:E635–46
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, Han Z, Polonsky KS, Permutt MA. (2004). Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 114:928–36.
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. (2001). Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108:1631–8.
   PubMed Web of Science ®Google Scholar
• Bhaskar PT, Hay N. (2007). The two TORCs and Akt. Dev Cell 12:487–502.
   PubMed Web of Science ®Google Scholar
• Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A, Zierath JR. (2006). siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 4:89–96.
   PubMed Web of Science ®Google Scholar
• Bozulic L, Surucu B, Hynx D, Hemmings BA. (2008). PKB[alpha]/Akt1 Acts Downstream of DNA-PK in the DNA double-strand break response and promotes survival. Molecular Cell 30:203–213.
   PubMed Web of Science ®Google Scholar
• Brazil DP, Hemmings BA. (2001). Ten years of protein kinase B signalling: a hard Akt to follow. Trends in Biochemical Sciences 26:657–664.
   PubMed Web of Science ®Google Scholar
• Brazil DP, Park J, Hemmings BA. (2002). PKB binding proteins: Getting in on the Akt. Cell 111:293–303.
   PubMed Web of Science ®Google Scholar
• Brennesvik EO, Ktori C, Ruzzin J, Jebens E, Shepherd PR, Jensen J. (2005). Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline. Cell Signal 17:1551–9.
   PubMed Web of Science ®Google Scholar
• Brozinick Jr JT, Roberts BR, Dohm GL. (2003). Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes 52:935–41.
   PubMed Web of Science ®Google Scholar
• Buzzi F, Xu L, Zuellig RA, Boller SB, Spinas GA, Hynx D, Chang Z, Yang Z, Hemmings BA, Tschopp O, et al. (2010). Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. Mol Cell Biol 30:601–12.
   PubMed Web of Science ®Google Scholar
• Calera MR, Martinez C, Liu H, Jack AK, Birnbaum MJ, Pilch PF. (1998). Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem 273:7201–4.
   PubMed Web of Science ®Google Scholar
• Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, et al. (2007). A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448:439–44.
   PubMed Web of Science ®Google Scholar
• Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K, et al. (2001). Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15:2203–8.
   PubMed Web of Science ®Google Scholar
• Chin YR, Toker, A. (2010). The actin-bundling protein palladin is an akt1-specific substrate that regulates breast cancer cell migration. Molecular Cell 38:333–44.
   PubMed Web of Science ®Google Scholar
• Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw 3rd EB, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. (2001a). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728–31.
   PubMed Web of Science ®Google Scholar
• Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. (2001b). Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349–52.
   PubMed Web of Science ®Google Scholar
• Cleasby ME, Reinten TA, Cooney GJ, James DE, Kraegen EW. (2007). Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol 21:215–28.
   PubMed Web of Science ®Google Scholar
• Contreras-Ferrat AE, Toro B, Bravo R, Parra V, Vasquez C, Ibarra C, Mears D, Chiong M, Jaimovich, E, Klip A, et al. (2010). An inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes. Endocrinology 151:4665–77.
   PubMed Web of Science ®Google Scholar
• Defronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. (1981). The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000–7.
   PubMed Web of Science ®Google Scholar
• Dummler B, Tschopp O, Hynx D, Yang ZZ, Dirnhofer S, Hemmings BA. (2006). Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol 26:8042–51.
   PubMed Web of Science ®Google Scholar
• Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, De Jong R, Oltersdorf T, et al. (2005). Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25:1869–78.
   PubMed Web of Science ®Google Scholar
• Elghazi L, Rachdi L, Weiss AJ, Cras-Meneur C, Bernal-Mizrachi E. (2007). Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab 9 Suppl 2:147–57.
   Google Scholar
• Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, et al. (2003). Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112:197–208.
   PubMed Web of Science ®Google Scholar
• Gonzalez E, McGraw TE. (2009). Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling. Proc Natl Acad Sci USA 106:7004–9.
   PubMed Web of Science ®Google Scholar
• Guilherme A, Czech MP. (1998). Stimulation of IRS-1-associated phosphatidylinositol 3-kinase and Akt/protein kinase B but not glucose transport by beta1-integrin signaling in rat adipocytes. J Biol Chem 273:33119–22.
   PubMed Web of Science ®Google Scholar
• Haga S, Ogawa W, Inoue H, Terui K, Ogino T, Igarashi R, Takeda K, Akira S, Enosawa S, Furukawa H, et al. (2005). Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. Journal of Hepatology 43:799–807.
   PubMed Web of Science ®Google Scholar
• Hajduch E, Alessi DR, Hemmings BA, Hundal HS. (1998). Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47:1006–13.
   PubMed Web of Science ®Google Scholar
• Hanada M, Feng J, Hemmings BA. (2004). Structure, regulation and function of PKB/AKT––a major therapeutic target. Biochimica et Biophysica Acta (BBA)− Proteins & Proteomics 1697:3–16.
   PubMed Web of Science ®Google Scholar
• He L, Hou X, Kanel G, Zeng N, Galicia V, Wang Y, Yang J, Wu H, Birnbaum MJ, Stiles BL. (2010). The critical role of AKT2 in hepatic steatosis induced by PTEN loss. Am J Pathol 176:2302–8.
   PubMed Web of Science ®Google Scholar
• Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, et al. 2003. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112:1521–32.
   PubMed Web of Science ®Google Scholar
• Heron-Milhavet L, Franckhauser C, Rana V, Berthenet C, Fisher D, Hemmings BA, Fernandez A, Lamb NJC. (2006). Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Molecular and Cellular Biology 26:8267–80.
   PubMed Web of Science ®Google Scholar
• Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE. (2008). IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7:421–33.
   PubMed Web of Science ®Google Scholar
• Horie Y, Suzuki A, Kataoka E, Sasaki T, Hamada K, Sasaki J, Mizuno K, Hasegawa G, Kishimoto H, Iizuka M, et al. (2004). Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. The Journal of Clinical Investigation 113:1774–83.
   PubMed Web of Science ®Google Scholar
• Jensen J, Lai YC. (2009). Regulation of muscle glycogen synthase phosphorylation and kinetic properties by insulin, exercise, adrenaline and role in insulin resistance. Arch Physiol Biochem 115:13–21.
   PubMedGoogle Scholar
• Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, Czech MP. (2003). Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 100:7569–74.
   PubMed Web of Science ®Google Scholar
• Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA. (1991). Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 88:4171–5.
   PubMed Web of Science ®Google Scholar
• Katome T, Obata T, Matsushima R, Masuyama N, Cantley LC, Gotoh Y, Kishi K, Shiota H, Ebina Y. (2003). Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J Biol Chem 278:28312–23.
   PubMed Web of Science ®Google Scholar
• Kitamura, T., Ogawa, W., Sakaue, H., Hino, Y., Kuroda, S., Takata, M., Matsumoto, M., Maeda, T., Konishi, H., Kikkawa, U, et al. (1998). Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol 18:3708–17.
   PubMed Web of Science ®Google Scholar
• Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, et al. 2000. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49:1880–89.
   PubMed Web of Science ®Google Scholar
• Lawrence JC, Roach PJ. (1997). New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46:541–7.
   PubMed Web of Science ®Google Scholar
• Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ. (2009). Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metabolism 10:405–18.
   PubMed Web of Science ®Google Scholar
• Ling HY, Ou HS, Feng SD, Zhang XY, Tuo QH, Chen LX, Zhu BY, Gao ZP, Tang CK, Yin WD, et al. (2009). Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3–L1 adipocytes. Clinical and Experimental Pharmacology and Physiology 36:e32–9
   PubMed Web of Science ®Google Scholar
• Lingohr MK, Dickson LM, Wrede CE, Briaud I, McCuaig JF, Myers Jr MG, Rhodes CJ. (2003). Decreasing IRS-2 expression in pancreatic beta-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression. Mol Cell Endocrinol 209:17–31.
   PubMed Web of Science ®Google Scholar
• Maedler, K. (2008). Beta cells in type 2 diabetes− a crucial contribution to pathogenesis. Diabetes Obes Metab 10:408–20.
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. (2007). AKT/PKB signaling: Navigating downstream. Cell 129:1261–1274.
   PubMed Web of Science ®Google Scholar
• Mohanty S, Spinas GA, Maedler K, Zuellig RA, Lehmann R, Donath MY, Trub T, Niessen, M. (2005). Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis. Exp Cell Res 303:68–78.
   PubMed Web of Science ®Google Scholar
• Newgard CB.(2003). Regulation of glucose metabolism in the liver. International Textbook of Diabetes Mellitus. 3rd edn. Chichester, UK: John Wiley & Sons.
   Google Scholar
• Niessen, M. (2006). On the role of IRS2 in the regulation of functional beta-cell mass. Arch Physiol Biochem 112:65–73.
   PubMedGoogle Scholar
• Ono H, Shimano H, Katagiri H, Yahagi N, Sakoda H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Viana AYI, et al. (2003). Hepatic akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52:2905–13.
   PubMed Web of Science ®Google Scholar
• Park S, Dong X, Fisher TL, Dunn S, Omer AK, Weir G, White MF. (2006). Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J Biol Chem 281:1159–68.
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Arnolds DE, Fujii N, Kramer HF, Hirshman MF, Goodyear LJ. (2006). Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle. Am J Physiol Endocrinol Metab 291:E1031–7
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Aschenbach WG, Hirshman MF, Goodyear LJ. (2003). Akt signaling in skeletal muscle: regulation by exercise and passive stretch. Am J Physiol Endocrinol Metab 285:E1081–8
   PubMed Web of Science ®Google Scholar
• Sakamoto, K., Hirshman MF, Aschenbach WG, Goodyear LJ. (2002). Contraction regulation of Akt in rat skeletal muscle. J Biol Chem 277:11910–7.
   PubMedGoogle Scholar
• Shepherd PR. (2005). Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiol Scand 183:3–12.
   PubMedGoogle Scholar
• Shulman GI, Rothman DL, Jue T, Stein P, Defronzo RA, Shulman RG. (1990). Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223–8.
   PubMed Web of Science ®Google Scholar
• Staal SP, Hartley JW, Rowe WP. (1977). Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci USA 74:3065–7.
   PubMed Web of Science ®Google Scholar
• Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim Y-J, Sherwin R, Devaskar S, Lesche R, Magnuson MA, et al. (2004). Live-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proceedings of the National Academy of Sciences of the United States of America 101:2082–7.
   PubMed Web of Science ®Google Scholar
• Takamoto I, Terauchi Y, Kubota N, Ohsugi M, Ueki K, Kadowaki T. (2008). Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance. Diabetes Obes Metab 10 Suppl 4:147–56.
   Google Scholar
• Taniguchi CM, Kondo T, Sajan M, Luo J, Bronson R, Asano T, Farese R, Cantley LC, Kahn CR. (2006). Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKC[lambda]/[zeta]. Cell Metabolism 3:343–53.
   PubMed Web of Science ®Google Scholar
• Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T, Michaelis T, Frahm J, Hemmings BA. (2005). Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 132:2943–54.
   PubMed Web of Science ®Google Scholar
• Turinsky J, Damrau-Abney A. (1999). Akt kinases and 2-deoxyglucose uptake in rat skeletal muscles in vivo: study with insulin and exercise. Am J Physiol 276:R277–82
   PubMed Web of Science ®Google Scholar
• Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ. (2001). Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7:1133–7.
   PubMed Web of Science ®Google Scholar
• Whitehead JP, Soos MA, Aslesen R, O’Rahilly S, Jensen J. (2000). Contraction inhibits insulin-stimulated insulin receptor substrate-1/2-associated phosphoinositide 3-kinase activity, but not protein kinase B activation or glucose uptake, in rat muscle. Biochem J 349 Pt 3:775–81.
   Google Scholar
• Withers D, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI., et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–4.
   PubMed Web of Science ®Google Scholar
• Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ. (2002). Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 277:49676–84.
   PubMed Web of Science ®Google Scholar
• Xu L, Spinas GA, Niessen M. (2010). ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport. Horm Metab Res 42:643–51.
   PubMed Web of Science ®Google Scholar
• Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, Hemmings BA. (2003). Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278:32124–31.
   PubMed Web of Science ®Google Scholar
• Zhao W-Q, Townsend M. (2009). Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease. Biochimica et Biophysica Acta (BBA)− Molecular Basis of Disease 1792:482–496.
   PubMed Web of Science ®Google Scholar
• Zhuravleva E, Tschopp O, Hemmings BA. (2010). Role of PKB/Akt in liver diseases. In: Dufour J-F, Clavien P–,A, editors. Signaling pathways in liver diseases. Berlin/Heidelberg: Springer.
   Google Scholar